Simulations Plus (SLP) Signs Additional Collaboration Agreement  
6/25/2012 10:26:28 AM

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, announced today that it has signed a collaboration agreement with a top-5 pharmaceutical company to add a transdermal and subcutaneous dosing model within its industry gold standard GastroPlus™ simulation software program.